Please Wait
Applying Filters...
menu
    • menu
    Coral

    Virtual Booth

    Contact Supplier

    China’s top API & intermediate manufacturer, delivering advanced CMO/CDMO solutions to 60+ countries, empowering global health progress

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Alchem offers Botanical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    Avacopan

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Amgen to Present Rare Autoimmune and Inflammatory Data at EULAR
    Amgen to Present Rare Autoimmune and Inflammatory Data at EULAR

    03 Jun 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/amgen-to-present-new-data-across-rare-autoimmune-and-inflammatory-diseases-at-eular-2026-302790204.html

    PR NEWSWIRE
    03 Jun 2026
    Share Share
    Amgen Updates Tavneos Label In Japan Amid Liver Injury Review
    Amgen Updates Tavneos Label In Japan Amid Liver Injury Review

    21 May 2026

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/amgens-tavneos-facing-liver-injury-scrutiny-gets-label-update-patient-starts-resume-japan

    FIERCE PHARMA
    21 May 2026
    Share Share
    Amgen Backs Tavneos Despite Japan Liver Toxicity Reports
    Amgen Backs Tavneos Despite Japan Liver Toxicity Reports

    19 May 2026

    // ENDPOINTS

    https://endpoints.news/amgen-stands-by-rare-disease-drug-tavneos-amid-japan-liver-toxicity-report/

    ENDPOINTS
    19 May 2026
    Share Share
    Amgen's Rare Disease Drug Linked to Deaths with- liver injuries
    Amgen's Rare Disease Drug Linked to Deaths with- liver injuries

    15 May 2026

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/amgens-rare-disease-drug-linked-deaths-liver-injuries-japan-wsj-reports-2026-05-15/

    REUTERS
    15 May 2026
    Share Share
    InflaRx: Favorable Izicopan Metabolite Profile in Humans
    InflaRx: Favorable Izicopan Metabolite Profile in Humans

    04 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/04/3286600/0/en/inflarx-reports-favorable-reactive-metabolite-profile-for-izicopan-in-human-liver-microsomes.html

    GLOBENEWSWIRE
    04 May 2026
    Share Share
    Amgen Updates Tavneos Label Amid FDA Withdrawal Push
    Amgen Updates Tavneos Label Amid FDA Withdrawal Push

    01 May 2026

    // ENDPOINTS

    https://endpoints.news/amgen-files-update-to-tavneos-label-as-fda-escalates-push-to-withdraw/

    ENDPOINTS
    01 May 2026
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.